In CRC models, the predominant expression of CYP2W1, CYP2S1, CYP1B1, and CYP2J2 suggests their potential functional involvement in tumour metabolism, xenobiotic processing and disease progression [16–19]. The gene discussed is CYP2J2; the disease is neoplasm.